Importance of the Mean Rate of Pressure Change of the Pulmonary Artery (dP/dt mean PA) in Patients with Pulmonary Arterial Hypertension
- PMID: 37435554
- PMCID: PMC10332940
- DOI: 10.1055/s-0043-1769932
Importance of the Mean Rate of Pressure Change of the Pulmonary Artery (dP/dt mean PA) in Patients with Pulmonary Arterial Hypertension
Abstract
Background Pulmonary arterial hypertension (PAH) is a rare disease of cardiopulmonary circulation characterized by elevated pressure in the pulmonary artery. The right-heart catheter is the gold standard for diagnosis, but there is interest in identifying additional prognostic indicators. The aim of this study was to examine the importance of the rate of pressure change of the pulmonary artery (dP/dt mean PA) in patients with PAH. Methods We retrospectively analyzed data from 142 patients with PAH (exclusively clinical group 1) and examined the statistical correlation of dP/dt mean PA with vascular, right ventricular, and clinical parameters. Data was collected mostly from the right heart catheterization and the transthoracal echocardiography at presentation. Results dP/dt mean PA showed a significant correlation with systolic pressure of the pulmonary artery ( n = 142, R 2 = 56%, p < 0.001), pulmonary vascular resistance ( n = 142, R 2 = 51%, p < 0.001), the rate of pressure change in the right ventricle ( n = 142, R 2 = 53%, p < 0.001), and the right ventricular fractional area change ( n = 110, R 2 = 51%, p < 0.001). Receiver operating characteristic curve analysis showed that dP/dt mean PA had the highest prognostic value in predicting increase in the 6-minute walk test and decrease in the N-terminal-probrain natriuretic peptide after the initiation of PAH therapy, with an area under the curve of 0.73. Conclusion Our findings suggest that dP/dt mean PA may be a useful prognostic indicator in the treatment of patients with PAH, and further research is warranted to validate this parameter.
Keywords: 6-minute walk test; pulmonary artery; pulmonary hypertension.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ).
Conflict of interest statement
Conflict of Interest None declared.
Figures




References
-
- Humbert M, Sitbon O, Chaouat A. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173(09):1023–1030. - PubMed
-
- Simonneau G, Gatzoulis M A, Adatia I.Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 201362(25, Suppl):D34–D41. - PubMed
-
- ESC Scientific Document Group . Galiè N, Humbert M, Vachiery J L. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur Heart J. 2016;37(01):67–119. - PubMed
-
- Westerof N, Stergiopulos N, Noble M. 2nd ed. Springer; 2010. Snapshots of Hemodynamics; pp. 3–155.
-
- European Network for Non-invasive Investigation of Large Arteries . Laurent S, Cockcroft J, Van Bortel L. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588–2605. - PubMed
LinkOut - more resources
Full Text Sources